Coologics Secures $3M for Drug-Free Vaginal Infection Treatment Device

grdirks
Apr 24, 2025
1 min read

Coologics, a US-based clinical-stage medical device company, has successfully closed an oversubscribed seed funding round, raising over $3 million for its innovative vaginal infection treatment device, Vlisse.

Recent Posts

See All

Florida Angels Join $4.7M Hyperspectral Imaging Round, AI Writes up to One-Third of Microsoft's Code, and Why Clarity is Kindness

Coologics | Drug-free vaginal infection treatment Participating Groups: Ohio State Early Investor Network , Illini Angels Coologics is developing a drug-free intravaginal cooling device called Vlisse

Cleveland women's healthtech startup secures $3M, doubling initial target

A Cleveland-based clinical-stage medical device company announced it has closed an oversubscribed $3 million seed funding round, doubling the initial $1.5 million target. Read more.

COOLOGICS Initiates Multi-Center Clinical Trials for Vlisse

COOLOGICS , a clinical-stage medical device company, has announced the commencement of new, larger multi-center, open-label clinical trials for its innovative product, Vlisse. These trials will begin

Comments

Vlisse™ is a Class I Device in the European Union CE Mark Pending and a FDA Class II device pending FDA clearance.